AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41

Authors: VANDERWESTERLAKEN LA NAAKTGEBOREN N HELMERHORST FM
Citation: La. Vanderwesterlaken et al., EVALUATION OF PREGNANCY RATES AFTER INTRAUTERINE INSEMINATION ACCORDING TO INDICATION, AGE, AND SPERM PARAMETERS, Journal of assisted reproduction and genetics, 15(6), 1998, pp. 359-364

Authors: OEI SG HELMERHORST FM BLOEMENKAMP KWM HOLLANTS FAM MEERPOEL DEM KEIRSE MJNC
Citation: Sg. Oei et al., EFFECTIVENESS OF THE POSTCOITAL TEST - RANDOMIZED CONTROLLED TRIAL, BMJ. British medical journal, 317(7157), 1998, pp. 502-505

Authors: VANDERWEIDEN RMF HELMERHORST FM KEIRSE MJNC
Citation: Rmf. Vanderweiden et al., WHICH PROSTANOID METABOLITES SHOULD BE DETERMINED FOR THE STUDY OF REPRODUCTIVE PROCESSES, Prostaglandins, leukotrienes and essential fatty acids, 58(3), 1998, pp. 205-207

Authors: BLOEMENKAMP KWM HELMERHORST FM DERSJANTROORDA MD DEBOER R MEYER P SPIELMANN D KLUFT C
Citation: Kwm. Bloemenkamp et al., A COMPARATIVE CLINICAL INVESTIGATION OF 2 LOW-DOSE ORAL-CONTRACEPTIVES CONTAINING EITHER 75 MU-G GESTODENE OR 150 MU-G DESOGESTREL COMBINEDWITH 20 MU-G ETHINYLESTRADIOL - EFFECT ON HEMOSTASIS, LIPID-METABOLISM AND CARBOHYDRATE-METABOLISM, Gynecological endocrinology, 12, 1998, pp. 21-30

Authors: BLOEMENKAMP KWM ROSENDAAL FR HELMERHORST FM KOSTER T BERTINA RM VANDENBROUCKE JP
Citation: Kwm. Bloemenkamp et al., HEMOSTATIC EFFECTS OF ORAL-CONTRACEPTIVES IN WOMEN WHO DEVELOPED DEEP-VEIN THROMBOSIS WHILE USING ORAL-CONTRACEPTIVES, Thrombosis and haemostasis, 80(3), 1998, pp. 382-387

Authors: HELMERHORST FM ROSENDAAL FR VANDENBROUCKE JP
Citation: Fm. Helmerhorst et al., THE PILL AND VENOUS THROMBOEMBOLISM - A DISARRAY OF SEVERAL LAYERS OFDEBATE, Human reproduction, 13(5), 1998, pp. 1119-1120

Authors: HELMERHORST FM ROSENDAAL FR VANDENBROUCKE JP
Citation: Fm. Helmerhorst et al., VENOUS THROMBOEMBOLISM AND THE PILL - THE WHO TECHNICAL REPORT ON CARDIOVASCULAR-DISEASE AND STEROID-HORMONE CONTRACEPTION - STATE-OF-THE-ART, Human reproduction (Oxford. Print), 13(11), 1998, pp. 2981-2983

Authors: HELMERHORST FM
Citation: Fm. Helmerhorst, COST-EFFECTIVE WORK-UP FOR INFERTILITY AND COST IN GENERAL, Human reproduction (Oxford. Print), 13, 1998, pp. 131-131

Authors: VANDENBROUCKE JP HELMERHORST FM ROSENDAAL FR
Citation: Jp. Vandenbroucke et al., EPIDEMIOLOGY OF ORAL-CONTRACEPTIVES AND CARDIOVASCULAR-DISEASE, Annals of internal medicine, 129(9), 1998, pp. 747-747

Authors: VANDENBROUCKE JP ROSENDAAL FR HELMERHORST FM
Citation: Jp. Vandenbroucke et al., SCIENTIFIC PROBLEMS WITH A NONCAUSAL ARTIFACT - REPLY, American journal of obstetrics and gynecology, 178(5), 1998, pp. 1106-1107

Authors: BLOEMENKAMP KWM ROSENDAAL FR HELMERHORST FM KOSTER T BERTINA RM VANDENBROUCKE JP
Citation: Kwm. Bloemenkamp et al., HEMOSTATIC EFFECTS OF ORAL-CONTRACEPTIVES IN WOMEN WHO HAD PREVIOUSLYDEVELOPED DEEP-VEIN THROMBOSIS WHILE USING ORAL-CONTRACEPTIVES, Thrombosis and haemostasis, 1997, pp. 786-786

Authors: BLOEMENKAMP KWM ROSENDAAL FR BULLER HR HELMERHORST FM COLLY LP VANDENBROUCKE JP
Citation: Kwm. Bloemenkamp et al., THE ASSOCIATION BETWEEN ORAL-CONTRACEPTIVES AND VENOUS THROMBOSIS IS NOT EXPLAINED BY DIAGNOSTIC SUSPICION AND REFERRAL BIAS, Thrombosis and haemostasis, 1997, pp. 2903-2903

Authors: HELMERHORST FM BLOEMENKAMP KWM ROSENDAAL FR VANDENBROUCKE JP
Citation: Fm. Helmerhorst et al., ORAL-CONTRACEPTIVES AND THROMBOTIC DISEASE - RISK OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 78(1), 1997, pp. 327-333

Authors: OEI SG HELMERHORST FM BLOEMENKAMP KWM DERSJANTROORDA M KEIRSE MJNC
Citation: Sg. Oei et al., PREDICTING OPTIMAL CERVICAL-MUCUS FOR INFERTILITY DIAGNOSIS, European journal of obstetrics, gynecology, and reproductive biology, 73(1), 1997, pp. 63-66

Authors: HELMERHORST FM OEI SG KEIRSE MJNC
Citation: Fm. Helmerhorst et al., CLINICAL TUTORIAL IN EVIDENCE-BASED MEDICINE - THE PROGNOSTIC VALUE OF THE POSTCOITAL TEST, Human reproduction, 12, 1997, pp. 99-99

Authors: VANDENBROUCKE JP HELMERHORST FM BLOEMENKAMP KWM ROSENDAAL FR
Citation: Jp. Vandenbroucke et al., 3RD-GENERATION ORAL-CONTRACEPTIVES AND VENOUS THROMBOSIS, Lancet, 349(9053), 1997, pp. 731-731

Authors: VANDENBROUCKE JP BLOEMENKAMP KWM HELMERHORST FM ROSENDAAL FR
Citation: Jp. Vandenbroucke et al., RISK OF ORAL-CONTRACEPTIVES AND RECENCY OF MARKET INTRODUCTION, Contraception, 55(3), 1997, pp. 191-192

Authors: VANDENBROUCKE JP HELMERHORST FM BLOEMENKAMP KWM ROSENDAAL FR
Citation: Jp. Vandenbroucke et al., 3RD-GENERATION ORAL-CONTRACEPTIVE AND DEEP VENOUS THROMBOSIS - FROM EPIDEMIOLOGIC CONTROVERSY TO NEW INSIGHT IN COAGULATION, American journal of obstetrics and gynecology, 177(4), 1997, pp. 887-891

Authors: VANDENBROUCKE JP VANDERMEER FJM HELMERHORST FM ROSENDAAL FR
Citation: Jp. Vandenbroucke et al., FACTOR-V LEIDEN - SHOULD WE SCREEN ORAL-CONTRACEPTIVE USERS AND PREGNANT-WOMEN, BMJ. British medical journal, 313(7065), 1996, pp. 1127-1130

Authors: OEI SG BLOEMENKAMP KWM HELMERHORST FM NAAKTGEBOREN N KEIRSE MJNC
Citation: Sg. Oei et al., EVALUATION OF THE POSTCOITAL TEST FOR ASSESSMENT OF CERVICAL FACTOR INFERTILITY, European journal of obstetrics, gynecology, and reproductive biology, 64(2), 1996, pp. 217-220

Authors: RADEMAKERS J COENDERS A DERSJANTROORDA M HELMERHORST FM
Citation: J. Rademakers et al., A SURVEY STUDY OF ATTITUDES TO AND USE OF THE DOUBLE DUTCH METHOD AMONG UNIVERSITY-STUDENTS IN THE NETHERLANDS, British journal of family planning, 22(1), 1996, pp. 22-24

Authors: VANDENBROUCKE JP BLOEMENKAMP KWM HELMERHORST FM ROSENDAAL FR
Citation: Jp. Vandenbroucke et al., ORAL-CONTRACEPTIVES AND MORTALITY FROM VENOUS THROMBOEMBOLISM - REPLY, Lancet, 348(9034), 1996, pp. 1096-1097

Authors: VANDENBROUCKE JP HELMERHORST FM
Citation: Jp. Vandenbroucke et Fm. Helmerhorst, RISK OF VENOUS THROMBOSIS WITH HORMONE-REPLACEMENT THERAPY, Lancet, 348(9033), 1996, pp. 972-972

Authors: VANDENBROUCKE JP BLOEMENKAMP KWM HELMERHORST FM ROSENDAAL FR
Citation: Jp. Vandenbroucke et al., MORTALITY FROM VENOUS THROMBOEMBOLISM AND MYOCARDIAL-INFARCTION IN YOUNG-WOMEN IN THE NETHERLANDS, Lancet, 348(9024), 1996, pp. 401-402

Authors: VANDENBROUCKE JP BLOEMENKAMP KWM HELMERHORST FM BULLER HR ROSENDAAL FR
Citation: Jp. Vandenbroucke et al., SAFETY OF COMBINED ORAL-CONTRACEPTIVE PILLS - REPLY, Lancet, 347(9000), 1996, pp. 547-548
Risultati: 1-25 | 26-41